April 8 (Reuters) - Abbott Laboratories:
* Acquisition of Facet Biotech clears U.S. antitrust review
* Says expiration of Hart-Scott-Rodino waiting period satisfies one of the
conditions necessary for consummation of tender offer
* Says tender offer is scheduled to expire on Monday, April 19, 2010
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Acquisition of Facet Biotech clears U.S. antitrust review
* Says expiration of Hart-Scott-Rodino waiting period satisfies one of the
conditions necessary for consummation of tender offer
* Says tender offer is scheduled to expire on Monday, April 19, 2010
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
© 2010 AFX News
